$QCOM

Palkhiwala Akash J. sold $408K of QCOM

Palkhiwala Akash J. (EVP, CFO & COO) sold 2,500 shares of QUALCOMM INC/DE (QCOM) at an average of $163.26 ($161.77–$165.34, $0.41M total) across 5 trades on 2026-08-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Palkhiwala Akash J.
Published Aug 12, 2026, 10:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 10:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$QCOM
Neutral
high confidence
Mentioned
$QCOM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QCOMNeutralLow
01

Why it matters

The only disclosed new fact is the insider sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan; no fundamental company change is described.

02

Market read

Traders may note the same-day insider selling print, but the pre-arranged nature typically reduces signal strength versus unscheduled sales.

03

What to watch

The article does not state whether sales were part of tax planning, diversification, or compensation timing; without that context, interpreting directionality is unreliable.

Relevance 3/10Novelty 3/10Timing: Filed 2026-08-12 after-hours; reflects same-day insider selling activity.

Background

The article is a SEC Form 4 insider transaction disclosure for Qualcomm, reported by EVP, CFO & COO Akash Palkhiwala.

Company-level read

Ticker impact

$QCOMNeutralHigh confidence
Context

Qualcomm CFO Akash Palkhiwala sold about 2,500 shares in open-market trades on 2026-08-12 under a 10b5-1 plan, totaling $408,142.79.

Expected impact

Likely minimal near-term impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly marked as open-market and pre-arranged via 10b5-1, and the article provides no accompanying guidance, contract, litigation, or regulatory development.

Market effects

No sector read-through is provided beyond routine insider selling in a mega-cap semiconductor/telecom equipment name.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with internal views on valuation or liquidity needs, which some traders may still fade.

Key entities

  • QUALCOMM INC/DE

    Subject of the Form 4 insider transaction disclosure.

  • Akash J. Palkhiwala

    EVP, CFO & COO who sold shares in open-market trades under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QCOMMed

Qualcomm Faces Heating Setback in Galaxy S27

Qualcomm's next-gen chip, Snapdragon 8 Elite Extreme 6th Gen, faces heating issues, potentially delaying its use in Samsung's Galaxy S27 Ultra. Samsung may switch to its in-house Exynos 2700 chip, developed using a 2-nanometer process, which could impact Qualcomm's revenue and Samsung's semiconductor strategy. Industry experts suggest Qualcomm may struggle to resolve the heating issue quickly.

$QCOMMed

Qualcomm Vs. Arm: The Jury Verdict Is In. Who Came Out On Top?

A jury found Arm breached its agreement with Qualcomm and interfered with its Meta relationship, but rejected several other claims. Qualcomm was awarded $2 in damages, but key decisions on licensing and remedies remain with the judge. The outcome could impact future licensing talks and business practices. Arm also claimed victory, as it avoided substantial financial damages and defeated several claims.

$QCOMMed

Jury finds Arm guilty in licensing breach, Qualcomm awarded just $2 in total

A Delaware jury found Arm guilty of breaching a licensing agreement with Qualcomm and interfering with its business relations, awarding Qualcomm $2 in damages. Arm disputes the ruling, claiming it acted in good faith. Qualcomm seeks to stop paying royalties to Arm for five years, a decision pending with Judge Maryellen Noreika. The dispute began after Qualcomm's 2021 acquisition of Nuvia, with Qualcomm alleging Arm withheld chip-testing tools and leaked threats to end a key license.

$ARMLow

Arm-Qualcomm legal fight ends in limited verdict, larger stakes remain

A Delaware jury found Arm breached its licensing agreement with Qualcomm, awarding $2 in damages. Qualcomm seeks to stop paying royalties, while Arm argues the provision is unenforceable. The dispute follows earlier legal battles over Nuvia's acquisition. Both companies are expanding into new markets. Analysts note the ruling reduces uncertainty but Qualcomm's PC market challenges remain.

$QCOMMed

Arm breached Qualcomm license agreement, jury finds

A jury found Arm breached its license agreement with Qualcomm, awarding Qualcomm $2. Qualcomm accused Arm of failing to provide software tools and interfering with a chip deal. Arm maintained it acted in good faith. The verdict is part of an ongoing legal dispute between the two companies.

$QCOMMed

Qualcomm at $175: The Narrative Shift Sending Capital Out The Door

Qualcomm (QCOM) reported fiscal Q3 with handset revenue down 20% YoY to $5.09B and automotive revenue up 61% to $1.59B. Non-GAAP EPS was $2.21, slightly missing estimates. Management raised its fiscal 2029 non-handset revenue target to $40B. The stock trades at a forward P/E of 20, with a PEG ratio of 0.88 and a free cash flow yield of 6.79%. Analysts have a $194 average target, with most rating it a Hold.